Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Effective for local tumors and distant metastases Immunotherapies use the body's own immune system to fight cancer cells. Plasmacytoid dendritic cells (pDCs), which are activated by Imiquimod via ...

Effective for local tumors and distant metastases Immunotherapies use the body's own immune system to fight cancer cells. Plasmacytoid dendritic cells (pDCs), which are activated by Imiquimod via ...

Dendritic cell therapy has emerged as a promising alternative for treating various forms of cancer, particularly in ...

Researchers studied the gene expression of lymphatic endothelial cells in melanoma (a type of skin cancer) and healthy mouse ...

A phase 2, multicenter, open-label study of AlloStim combined with anti-PD-L1 immunotherapy as 4L therapy in patients with MSS/pMMR metastatic colorectal cancer. This is an ASCO Meeting Abstract from ...

Immunotherapies use the body's own immune system to fight cancer cells. Plasmacytoid dendritic cells (pDCs), which are activated by Imiquimod via TLR7/8, play an important role in this process.

Miriam Merad, Mount Sinai, USA, has studied how cells in the immune system affect the body’s ability to fight tumours. Her ...